Monday, December 10, 2012 Sunday, December 9, 2012 Friday, December 7, 2012- 3 Horrendous Health-Care Stocks This Weekat Motley Fool (Fri, Dec 7)
- Why Did Amarin’s Financing Announcement Spark a Sell-Off?at Wall St. Cheat Sheet (Fri, Dec 7)
- Amarin's Wall Street Beating: Will It Recover?at Motley Fool (Fri, Dec 7)
- Should The Amylin Example Discourage Amarin Shareholders?at Seeking Alpha (Fri, Dec 7)
- U.S. Stocks Rise on Employment Data Amid Budget Talksat Bloomberg (Fri, Dec 7)
- Amarin Falls After Financing Suggests Buyout Not Imminentat Bloomberg (Fri, Dec 7)
- No Buy-Out, No Support For AMRN Suggests Investors Will Dumpat Seeking Alpha (Fri, Dec 7)
- Midday Nasdaq Falls on Apple While Amarin Dropsat Minyanville (Fri, Dec 7)
- Amarin: "You Just Have to Get on With It"at Motley Fool (Fri, Dec 7)
- Why Amarin Shares Got Crushedat Motley Fool (Fri, Dec 7)
- Alexion Pharmaceuticals and More Big Movers in Healthcare on December 7, 2012at Investopedia (Fri, Dec 7)
- The Nasdaq Now: Warning Shots Fired for Smith & Wessonat Minyanville (Fri, Dec 7)
- Alexion Pharmaceuticals and Other Big Movers on the Nasdaq on December 7, 2012at Investopedia (Fri, Dec 7)
- Midday Movers: CSCO, CTXS & Moreat CNBC (Fri, Dec 7)
- Amarin's Stock Drops on Plan to Sell Heart Drug Vascepa Aloneat Minyanville (Fri, Dec 7)
- PowerShares QQQ Trust and Amarin Corporation Among Most Active Stocks in Nasdaq Pre-Marketat Minyanville (Fri, Dec 7)
Add AMRN News to My Yahoo!  | |
|